90 related articles for article (PubMed ID: 24918049)
1. Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling.
Santhekadur PK; Akiel M; Emdad L; Gredler R; Srivastava J; Rajasekaran D; Robertson CL; Mukhopadhyay ND; Fisher PB; Sarkar D
FEBS Open Bio; 2014; 4():353-61. PubMed ID: 24918049
[TBL] [Abstract][Full Text] [Related]
2. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
[TBL] [Abstract][Full Text] [Related]
3. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).
Jariwala N; Rajasekaran D; Srivastava J; Gredler R; Akiel MA; Robertson CL; Emdad L; Fisher PB; Sarkar D
Int J Oncol; 2015 Feb; 46(2):465-73. PubMed ID: 25405367
[TBL] [Abstract][Full Text] [Related]
4. Tudor staphylococcal nuclease: biochemistry and functions.
Gutierrez-Beltran E; Denisenko TV; Zhivotovsky B; Bozhkov PV
Cell Death Differ; 2016 Nov; 23(11):1739-1748. PubMed ID: 27612014
[TBL] [Abstract][Full Text] [Related]
5. Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.
Emdad L; Janjic A; Alzubi MA; Hu B; Santhekadur PK; Menezes ME; Shen XN; Das SK; Sarkar D; Fisher PB
Neuro Oncol; 2015 Mar; 17(3):419-29. PubMed ID: 25216670
[TBL] [Abstract][Full Text] [Related]
6. AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.
Srivastava J; Robertson CL; Rajasekaran D; Gredler R; Siddiq A; Emdad L; Mukhopadhyay ND; Ghosh S; Hylemon PB; Gil G; Shah K; Bhere D; Subler MA; Windle JJ; Fisher PB; Sarkar D
Cancer Res; 2014 Aug; 74(16):4364-77. PubMed ID: 25125681
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice.
Srivastava J; Siddiq A; Gredler R; Shen XN; Rajasekaran D; Robertson CL; Subler MA; Windle JJ; Dumur CI; Mukhopadhyay ND; Garcia D; Lai Z; Chen Y; Balaji U; Fisher PB; Sarkar D
Hepatology; 2015 Mar; 61(3):915-29. PubMed ID: 25065684
[TBL] [Abstract][Full Text] [Related]
8. Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney disease
Patel S; Tang J; Overstreet JM; Anorga S; Lian F; Arnouk A; Goldschmeding R; Higgins PJ; Samarakoon R
FASEB J; 2019 Sep; 33(9):9797-9810. PubMed ID: 31095421
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis.
Huang WT; Akhter H; Jiang C; MacEwen M; Ding Q; Antony V; Thannickal VJ; Liu RM
Exp Gerontol; 2015 Jan; 61():62-75. PubMed ID: 25451236
[TBL] [Abstract][Full Text] [Related]
10. [Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker
for Lung Adenocarcinoma].
Zhang R; Huang H; Zhu G; Wu D; Chen C; Cao P; Ding C; Liu H; Chen J; Li Y
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):25-37. PubMed ID: 38296623
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal nuclease and tudor domain containing 1-mediated MicroRNA decay.
Liu C; Cong Y; Chen L; Lv F; Cheng L; Song Y; Xing Y
Neoplasia; 2024 Jan; 47():100963. PubMed ID: 38176295
[TBL] [Abstract][Full Text] [Related]
12. The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator.
Shiragannavar VD; Sannappa Gowda NG; Puttahanumantharayappa LD; Karunakara SH; Bhat S; Prasad SK; Kumar DP; Santhekadur PK
Front Pharmacol; 2023; 14():1135952. PubMed ID: 36909161
[No Abstract] [Full Text] [Related]
13. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma.
Oura K; Morishita A; Tani J; Masaki T
J Hepatocell Carcinoma; 2022; 9():1279-1298. PubMed ID: 36545268
[TBL] [Abstract][Full Text] [Related]
14. Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.
Noureldeen AFH; Aziz SW; Shouman SA; Mohamed MM; Attia YM; Ramadan RM; Elhady MM
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294202
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Recent advances in the understanding of hepatocellular carcinogenesis.
Banini BA; Mehta R; Santhekadur PK
Front Oncol; 2022; 12():963998. PubMed ID: 35936725
[No Abstract] [Full Text] [Related]
16. Genetic variants associated mRNA stability in lung.
Li JR; Tang M; Li Y; Amos CI; Cheng C
BMC Genomics; 2022 Mar; 23(1):196. PubMed ID: 35272635
[TBL] [Abstract][Full Text] [Related]
17. Nucleases as molecular targets for cancer diagnosis.
Balian A; Hernandez FJ
Biomark Res; 2021 Nov; 9(1):86. PubMed ID: 34809722
[TBL] [Abstract][Full Text] [Related]
18. The Role of the PRMT5-SND1 Axis in Hepatocellular Carcinoma.
Wright T; Wang Y; Bedford MT
Epigenomes; 2021 Mar; 5(1):. PubMed ID: 33768972
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and Angiotensin Receptors 1 and 2-Multifunctional System in Cells Biology, What Do We Know?
Ziaja M; Urbanek KA; Kowalska K; Piastowska-Ciesielska AW
Cells; 2021 Feb; 10(2):. PubMed ID: 33673178
[TBL] [Abstract][Full Text] [Related]
20. miR-151a enhances Slug dependent angiogenesis.
Jury D; Daugaard I; Sanders KJ; Hansen LL; Agalliu D; Pedersen IM
Oncotarget; 2020 Jun; 11(23):2160-2171. PubMed ID: 32577162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
